
HOOK
HOOKIPA Pharma Inc.
$0.93
+$0.01(+0.65%)
16
Overall
--
Value
16
Tech
--
Quality
Market Cap
$9.04M
Volume
6.18K
52W Range
$0.72 - $4.74
Target Price
$2.00
Order:
Income Statement
Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
Total Revenue | $11.9M | $19.6M | $18.4M | $14.2M | $20.1M | $43.9M | ||
Total Revenue | $11.9M | $19.6M | $18.4M | $14.2M | $20.1M | $43.9M | ||
GROSS PROFIT | ||||||||
Gross Profit | $11.9M | $19.6M | $18.4M | $14.2M | $20.1M | $43.9M | ||
OPERATING EXPENSES | ||||||||
Operating Expenses | $63.0M | $72.9M | $100.1M | $79.5M | $105.1M | $88.7M | ||
Research & Development | $46.3M | $54.8M | $82.9M | $68.6M | $86.4M | $68.5M | ||
Research Expense | $46.3M | $54.8M | $82.9M | $68.6M | $86.4M | $68.5M | ||
Selling, General & Administrative | $16.7M | $18.1M | $17.3M | $18.8M | $18.6M | $20.2M | ||
General & Administrative Expenses | $16.7M | $18.1M | $17.3M | $18.8M | $18.6M | $20.2M | ||
Salaries & Wages | $5.6M | $8.7M | $7.6M | $5.0M | $2.3M | $2.0M | ||
Depreciation & Amortization | $1.1M | $1.7M | $2.1M | $1.9M | $3.6M | $2.8M | ||
Depreciation & Amortization | $1.1M | $1.7M | $2.1M | $1.9M | $3.6M | $2.8M | ||
Amortization | $800.0K | $700.0K | $800.0K | $800.0K | $400.0K | $200.0K | ||
Other Operating Expenses | $2.1M | $2.3M | $2.5M | $1.7M | $1.6M | $1.7M | ||
OPERATING INCOME | ||||||||
Operating income | $-51.1M | $-53.3M | $-81.7M | $-73.2M | $-97.7M | $-51.5M | ||
EBITDA | $-39.1M | $-39.1M | $-70.1M | $-60.4M | $-77.7M | $-40.9M | ||
NON-OPERATING ITEMS | ||||||||
Interest Expense (Non-Operating) | $877.0K | $786.0K | $898.0K | $687.0K | $317.0K | -- | ||
Intinc | $1.6M | $400.0K | $27.0K | $1.6M | $5.3M | $3.7M | ||
Net Non-Operating Interest Income/Expense | $710.0K | $-386.0K | $-871.0K | $946.0K | $5.3M | $3.7M | ||
Other Income/Expense | $-7.3M | $-9.6M | $-6.9M | $-392.0K | $12.5M | $7.2M | ||
Other Special Charges | $7.3M | $9.6M | $6.9M | $-392.0K | $313.0K | $-3.2M | ||
SPECIAL ITEMS | ||||||||
Restructring And Mn A Income | -- | -- | -- | -- | -- | $2.7M | ||
Special Income Charges | -- | -- | -- | -- | $-12.8M | $-2.7M | ||
Impairment of Capital Assets | -- | -- | -- | -- | $12.8M | $4.0M | ||
PRE-TAX INCOME | ||||||||
EBIT | $-42.2M | $-43.3M | $-74.8M | $-64.0M | $-81.2M | $-43.6M | ||
Pre-Tax Income | $-43.0M | $-44.1M | $-75.7M | $-64.7M | $-81.2M | $-43.6M | ||
INCOME TAX | ||||||||
Tax Provision | -- | -- | $1.0K | $230.0K | $368.0K | $-106.0K | ||
NET INCOME | ||||||||
Net Income | $-43.0M | $-44.1M | $-75.7M | $-64.9M | $-81.6M | $-43.5M | ||
Net Income (Continuing Operations) | $-43.0M | $-44.1M | $-75.7M | $-64.9M | $-81.6M | $-43.5M | ||
Net Income (Discontinued Operations) | $-43.0M | $-44.1M | $-75.7M | $-64.9M | $-81.6M | $-43.5M | ||
Net Income (Common Stockholders) | $-43.0M | $-44.1M | $-75.7M | $-64.9M | $-81.6M | $-43.5M | ||
Normalized Income | -- | -- | -- | -- | -- | $-33.0M | ||
TOTALS | ||||||||
Total Expenses | $63.0M | $72.9M | $100.1M | $79.5M | $105.1M | $88.7M | ||
SHARE & EPS DATA | ||||||||
Average Shares Outstanding | $17.9M | $26.0M | $32.8M | $6.6M | $9.5M | $12.5M | ||
Average Shares Outstanding (Diluted) | $17.9M | -- | $32.8M | $6.6M | $9.5M | $12.5M | ||
Shares Outstanding | $25.6M | $29.8M | $54.7M | $5.5M | $9.9M | $12.1M | ||
Basic EPS | $-2.41 | $-1.69 | $-2.3 | $-9.9 | $-8.6 | $-3.47 | ||
Basic EPS (Continuing Operations) | $-2.41 | $-1.69 | $-2.3 | $-9.9 | $-8.6 | $-3.47 | ||
Diluted EPS | $-2.41 | $-1.69 | $-2.3 | $-9.9 | $-8.6 | $-3.47 | ||
Diluted EPS (Continuing Operations) | -- | -- | $-2.3 | $-9.9 | $-8.6 | $-3.47 | ||
OTHER METRICS | ||||||||
Other Gand A | $16.7M | $18.1M | $17.3M | $18.8M | $18.6M | $20.2M | ||
Other Impairment Of Capital Assets | -- | -- | -- | -- | $12.8M | $4.0M | ||
Restruct | -- | -- | -- | -- | -- | $2.7M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | HOOK | $0.93 | +0.7% | 6.18K |
3 | ||||
4 | ||||
5 | ||||
6 |